Dataset Information


Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial.

ABSTRACT: Importance:There are high rates of maternal and newborn morbidity and mortality associated with opioid use disorder (OUD). Integrating OUD treatment in obstetric practices for pregnant and postpartum women via telemedicine can increase access to care and reduce the consequences of OUD. Evaluation of this care delivery model, however, is needed before widespread adoption. Objective:To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine vs in person. Design, Setting, and Participants:A nonrandomized controlled trial including 98 women receiving perinatal OUD treatment in 4 outpatient obstetric practices by telemedicine or in person and followed up until 6 to 8 weeks post partum was conducted from September 4, 2017, to December 31, 2018. Logistic regression with propensity score adjustment was applied to reduce group selection bias and control for potentially confounding variables. Interventions:Participants were seen weekly for 4 weeks, every 2 weeks for 4 weeks, and monthly thereafter and provided relapse prevention therapy and buprenorphine. Main Outcomes and Measures:The outcomes were retention in treatment, defined as uninterrupted addiction treatment during pregnancy through 6 to 8 weeks post partum; urine drug screen results at delivery and 6 to 8 weeks post partum; and a neonatal abstinence syndrome (NAS) diagnosis collected via electronic health records. Results:The mean (SD) age of the 98 pregnant women was 30.23 (5.12) years. Of these, 41 of 44 women (93.2%) in the telemedicine group and 48 of 54 women (88.9%) in the in-person group chose to continue treatment in the program after an initial evaluation. After propensity score weighting and doubly robust estimation, no significant differences were found between groups in retention in treatment at 6 to 8 weeks post partum (telemedicine: 80.4% vs in person: 92.7%; treatment effect, -12.2%; 95% CI, -32.3% to -4.4%). Similarly, after propensity score weighting and doubly robust estimation, there were no significant group differences in rates of NAS (telemedicine: 45.4% vs in person: 63.2%; treatment effect, -17.8%; 95% CI, -41.0% to 8.9%). Conclusions and Relevance:In this nonrandomized controlled trial, virtually integrated OUD care in obstetric practices produced similar maternal and newborn outcomes compared with in-person care. These findings may have important public health implications for combatting the opioid crisis and its consequences on pregnant women and their families. Future large randomized clinical trials are needed. Clinical Trial Registration:ClinicalTrials.gov identifier: NCT04049032.


PROVIDER: S-EPMC7042863 | BioStudies | 2020-01-01

SECONDARY ACCESSION(S): 10.15585/mmwr.mm6731a1

REPOSITORIES: biostudies

altmetric image


Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.

Haight Sarah C SC   Ko Jean Y JY   Tong Van T VT   Bohm Michele K MK   Callaghan William M WM  

MMWR. Morbidity and mortality weekly report 20180810 31

Opioid use by pregnant women represents a significant public health concern given the association of opioid exposure and adverse maternal and neonatal outcomes, including preterm labor, stillbirth, neonatal abstinence syndrome, and maternal mortality (1,2). State-level actions are critical to curbing the opioid epidemic through programs and policies to reduce use of prescription opioids and illegal opioids including heroin and illicitly manufactured fentanyl, both of which contribute to the epid  ...[more]

Similar Datasets

1000-01-01 | S-EPMC4325135 | BioStudies
2018-01-01 | S-EPMC6060005 | BioStudies
2020-01-01 | S-EPMC7233523 | BioStudies
2021-01-01 | S-EPMC7933917 | BioStudies
2020-01-01 | S-EPMC7251447 | BioStudies
2019-01-01 | S-EPMC6755683 | BioStudies
2013-01-01 | S-EPMC3734850 | BioStudies
2017-01-01 | S-EPMC5554969 | BioStudies
2020-01-01 | S-EPMC7603672 | BioStudies
2017-01-01 | S-EPMC5772976 | BioStudies